ReCor Medical, Inc.

ReCor Medical, Inc.

ReCor Medical, Inc.

Overview
Date Founded

2009

Headquarters

105 Comac Street,Ronkonkoma, NY 11779

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Medical Support Services
Hospitals & Patient Services

Company Description

ReCor Medical, Inc. develops novel therapeutic ultrasound catheter technologies The firm develops a therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The company was founded by Mano Iyer and Jacques Seguin in July 2009 and is headquartered in Palo Alto, CA.

Contact Data
Trying to get in touch with decision makers at ReCor Medical, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founder, Chief Operating Officer

President, Chief Executive Officer & Director

Vice President-Clinical Affairs

Clinical Operations Manager

Vice President-Regulatory & Medical Affairs

Board of Directors

Executive Director at Otsuka Holdings Co., Ltd.

Founder, Chief Operating Officer at ReCor Medical, Inc.

President, Chief Executive Officer & Director at ReCor Medical, Inc.

Director & Vice President at Otsuka Medical Devices Co., Ltd.

Paths to ReCor Medical, Inc.
Potential Connections via
Relationship Science
You
ReCor Medical, Inc.
Recent Transactions
Details Hidden

Otsuka Holdings Co., Ltd. purchases ReCor Medical, Inc. from Sofinnova Partners SAS

Investors
Details Hidden

Sofinnova Partners is an active manager which invests exclusively in life sciences and information technology firms in France, Europe, and to a limited extent, the US. They also have expertise in the clean technology sector. The firm aims to build companies from seed rounds to a trade sale or an IPO, investing in start-ups and early-stage companies with ambitious projects. They prefer to invest in companies capable of attracting European investors, contributing a minimum of 0.5 million euros per investment, and up to 20 million euros over several rounds of financing.Sofinnova Partners acts as lead or co-lead investor, taking a seat on the board of directors and seeking to bring added value to the investee company management team. The firm builds alliances, teaming up with other venture capitalists so that the investee company can cover their future capital needs and expand.In Information Technology, Sofinnova Partners aims to identify new trends and technological breakthroughs in areas such as materials, photonics and micro-electronics, embedded software and user interfaces for wireless and consumer electronics and IT infrastructure software solutions. The firm maintains a best-practice approach, teaming up with experts who combine scientific knowledge and business experience to help in their selection process.In Life Sciences, Sofinnova Partners focuses on ambitious seed and start-up projects developing new therapeutics in biopharmaceuticals and medical devices and give special attention to spin-offs or teams which leave companies in these two sectors, seeking to invest in companies which develop new products for unmet clinical needs, address big markets and which combine entrepreneurial and pharmaceutical experience.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ReCor Medical, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ReCor Medical, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and ReCor Medical, Inc..